VCEL – Vericel Corporation
Float Short %
9
Margin Of Safety %
-19
Put/Call OI Ratio
0.26
EPS Next Q Diff
-0.62
EPS Last/This Y
0.05
EPS This/Next Y
0.32
Price
37.3
Target Price
55.71
Analyst Recom
1.25
Performance Q
14.63
Relative Volume
1.42
Beta
1.17
Ticker: VCEL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-10 | VCEL | 38.96 | 0.19 | 0.25 | 770 |
| 2025-11-11 | VCEL | 41.08 | 0.19 | 0.00 | 771 |
| 2025-11-12 | VCEL | 40.47 | 0.21 | 999.99 | 702 |
| 2025-11-13 | VCEL | 39.8 | 0.22 | 0.00 | 703 |
| 2025-11-14 | VCEL | 39.85 | 0.22 | 0.00 | 703 |
| 2025-11-17 | VCEL | 39.4 | 0.22 | 0.00 | 703 |
| 2025-11-18 | VCEL | 39.02 | 0.22 | 0.00 | 706 |
| 2025-11-19 | VCEL | 38.94 | 0.22 | 0.00 | 706 |
| 2025-11-20 | VCEL | 37.81 | 0.22 | 0.00 | 706 |
| 2025-11-21 | VCEL | 39.57 | 0.22 | 0.04 | 706 |
| 2025-11-24 | VCEL | 38.64 | 0.22 | 1.67 | 627 |
| 2025-11-25 | VCEL | 42.55 | 0.23 | 0.00 | 642 |
| 2025-11-26 | VCEL | 40.46 | 0.23 | 1.08 | 650 |
| 2025-12-01 | VCEL | 38.78 | 0.25 | 0.00 | 673 |
| 2025-12-02 | VCEL | 37.63 | 0.25 | 0.50 | 673 |
| 2025-12-03 | VCEL | 37.37 | 0.25 | 0.36 | 673 |
| 2025-12-04 | VCEL | 36.76 | 0.27 | 0.00 | 668 |
| 2025-12-05 | VCEL | 36.23 | 0.26 | 0.00 | 672 |
| 2025-12-08 | VCEL | 37.3 | 0.26 | 999.99 | 673 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-11-10 | VCEL | 38.99 | 33.4 | - | 0.18 |
| 2025-11-11 | VCEL | 41.05 | -5.3 | - | 0.24 |
| 2025-11-12 | VCEL | 40.46 | -5.3 | - | 0.24 |
| 2025-11-13 | VCEL | 39.77 | -5.3 | - | 0.24 |
| 2025-11-14 | VCEL | 39.81 | -5.3 | - | 0.24 |
| 2025-11-17 | VCEL | 39.40 | 1.6 | - | 0.26 |
| 2025-11-18 | VCEL | 39.01 | 1.6 | - | 0.26 |
| 2025-11-19 | VCEL | 38.95 | 1.6 | - | 0.26 |
| 2025-11-20 | VCEL | 37.84 | 1.6 | - | 0.26 |
| 2025-11-21 | VCEL | 39.53 | 1.6 | - | 0.26 |
| 2025-11-24 | VCEL | 38.82 | 1.6 | - | 0.26 |
| 2025-11-25 | VCEL | 42.54 | 1.6 | - | 0.26 |
| 2025-11-26 | VCEL | 40.32 | 1.6 | - | 0.26 |
| 2025-12-01 | VCEL | 38.82 | 1.6 | - | 0.26 |
| 2025-12-02 | VCEL | 37.65 | 1.6 | - | 0.26 |
| 2025-12-03 | VCEL | 37.39 | 1.6 | - | 0.26 |
| 2025-12-04 | VCEL | 36.77 | 1.6 | - | 0.26 |
| 2025-12-05 | VCEL | 36.23 | 1.6 | - | 0.26 |
| 2025-12-08 | VCEL | 37.30 | 1.6 | - | 0.26 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-11-10 | VCEL | -10.10 | -5.66 | 9.32 |
| 2025-11-11 | VCEL | -10.10 | -5.66 | 9.32 |
| 2025-11-12 | VCEL | -11.10 | -5.66 | 8.88 |
| 2025-11-13 | VCEL | -11.48 | -5.66 | 8.88 |
| 2025-11-14 | VCEL | -11.48 | -5.66 | 8.89 |
| 2025-11-17 | VCEL | -7.27 | -1.71 | 8.89 |
| 2025-11-18 | VCEL | -7.27 | -1.71 | 8.89 |
| 2025-11-19 | VCEL | -7.27 | -1.71 | 8.89 |
| 2025-11-20 | VCEL | -7.27 | -1.71 | 8.89 |
| 2025-11-21 | VCEL | -7.27 | -1.71 | 8.89 |
| 2025-11-24 | VCEL | -7.27 | -4.28 | 8.88 |
| 2025-11-25 | VCEL | -7.46 | -4.28 | 8.88 |
| 2025-11-26 | VCEL | -7.46 | -4.28 | 9.00 |
| 2025-12-01 | VCEL | -7.46 | -4.39 | 9.00 |
| 2025-12-02 | VCEL | -7.46 | -4.39 | 9.00 |
| 2025-12-03 | VCEL | -7.46 | -4.39 | 9.00 |
| 2025-12-04 | VCEL | -6.93 | -4.39 | 9.00 |
| 2025-12-05 | VCEL | -6.93 | -4.39 | 9.00 |
| 2025-12-08 | VCEL | -6.93 | -4.38 | 9.00 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.54
Avg. EPS Est. Current Quarter
0.39
Avg. EPS Est. Next Quarter
-0.08
Insider Transactions
-6.93
Institutional Transactions
-4.38
Beta
1.17
Average Sales Estimate Current Quarter
90
Average Sales Estimate Next Quarter
63
Fair Value
30.03
Quality Score
78
Growth Score
91
Sentiment Score
18
Actual DrawDown %
45.9
Max Drawdown 5-Year %
-74
Target Price
55.71
P/E
154.9
Forward P/E
65.4
PEG
2.3
P/S
7.29
P/B
5.86
P/Free Cash Flow
92.56
EPS
0.24
Average EPS Est. Cur. Y
0.26
EPS Next Y. (Est.)
0.58
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
5.06
Relative Volume
1.42
Return on Equity vs Sector %
-22.8
Return on Equity vs Industry %
-7.9
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.08
EBIT Estimation
Vericel CorporationSector: Healthcare
Industry: Biotechnology
Employees: 357
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
stock quote shares VCEL – Vericel Corporation Stock Price stock today
news today VCEL – Vericel Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch VCEL – Vericel Corporation yahoo finance google finance
stock history VCEL – Vericel Corporation invest stock market
stock prices VCEL premarket after hours
ticker VCEL fair value insiders trading